XML 28 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1
Financial Instruments
12 Months Ended
Dec. 31, 2017
Financial Instruments, Owned, at Fair Value [Abstract]  
Financial Instruments
Financial Instruments
Investments
The following tables present information about our financial assets measured at fair value on a recurring basis as of December 31, 2017 and 2016 based on the three-tier fair value hierarchy (in thousands):
 
Fair Value Measurement at
December 31, 2017
Level 1
 
Level 2
 
Total
Description
 

 
 

 
 

Corporate bonds
$

 
149,069

 
$
149,069

Money market funds
32,832

 

 
32,832

U.S. Treasury securities

 
28,382

 
28,382

Asset-backed securities

 
27,738

 
27,738

Commercial paper

 
19,622

 
19,622

Agency securities

 
14,911

 
14,911

Total
$
32,832

 
$
239,722

 
$
272,554

Included in cash and cash equivalents
 

 
 

 
$
37,531

Included in marketable securities
 

 
 

 
$
235,023


 
Fair Value Measurement at
December 31, 2016
Level 1
 
Level 2
 
Total
Description
 
 
 
 
 
Corporate bonds
$

 
$
124,930

 
$
124,930

Asset-backed securities

 
32,567

 
32,567

U.S. Treasury securities

 
30,585

 
30,585

Commercial paper

 
9,787

 
9,787

Agency securities
$

 
$
8,489

 
$
8,489

Money market funds
$
3,545

 
$

 
$
3,545

Total
$
3,545

 
$
206,358

 
$
209,903

Included in cash and cash equivalents
 
 
 
 
$
3,545

Included in marketable securities
 
 
 
 
$
206,358


There were no transfers between fair value measurement levels during the years ended December 31, 2017 or 2016.
Gross unrealized gains or losses for cash equivalents and marketable securities as of December 31, 2017 and 2016 were not material. As of December 31, 2017 and 2016, there were no securities that were in an unrealized loss position for more than twelve months.
The following table classifies our marketable securities by contractual maturity as of December 31, 2017 and 2016 (in thousands):
 
December 31,
2017
 
December 31,
2016
Due in one year or less
$
137,576

 
$
131,190

Due after one year
97,447

 
75,168

Total
$
235,023

 
$
206,358


 
Derivative Instruments and Hedging
 
Our foreign currency exposures typically arise from expenditures associated with foreign operations and sales in foreign currencies of our products. To mitigate the effect of foreign currency fluctuations on our future cash flows and earnings, we enter into foreign currency forward contracts with certain financial institutions and designate those contracts as cash flow hedges. Our foreign currency forward contracts generally have maturities of 15 months or less. As of December 31, 2017, the balance of accumulated other comprehensive loss included an unrecognized net gain of $0.9 million related to the effective portion of changes in the fair value of foreign currency forward contracts designated as cash flow hedges. As of December 31, 2017, we have no cash collateral related to our cash flow hedges. We expect to reclassify a net gain of $1.0 million into earnings over the next 12 months associated with our cash flow hedges.
 
The following table presents information about our derivative instruments on the consolidated balance sheet as of December 31, 2017 and 2016 (in thousands):

 
December 31, 2017
Asset Derivatives
 
Liability Derivatives
Derivative Instrument
Balance Sheet Location
 
Fair Value
(Level 2)
 
Balance Sheet Location
 
Fair Value
(Level 2)
Foreign currency forward contracts
Other current assets
 
$
2,359

 
Accrued liabilities
 
$
1,220

Total
 
 
$
2,359

 
 
 
$
1,220



 
December 31, 2016
Asset Derivatives
 
Liability Derivatives
Derivative Instrument
Balance Sheet Location
 
Fair Value
(Level 2)
 
Balance Sheet Location
 
Fair Value
(Level 2)
Foreign currency forward contracts
Other current assets
 
$
868

 
Accrued liabilities
 
$
4,280

Total
 
 
$
868

 
 
 
$
4,280



Our foreign currency forward contracts had a total notional value of $139.7 million and $79.6 million as of December 31, 2017 and 2016, respectively.
 
The following table presents information about our derivative instruments on the statement of operations for the years ended December 31, 2017 and 2016 (in thousands):
 
 
 
Year Ended December 31, 2017
 
Year Ended December 31, 2016
Derivative Instrument
Location of Loss Reclassified into Earnings
 
Gain Recognized in AOCI
 
Loss Reclassified from AOCI into Earnings
 
Loss Recognized in AOCI
 
Loss Reclassified from AOCI into Earnings
Foreign currency forward contracts
Revenue, cost of revenue, operating expenses
 
$
3,663

 
$
(225
)
 
$
(3,174
)
 
$
(903
)
Total
 
 
$
3,663

 
$
(225
)
 
$
(3,174
)
 
$
(903
)


All derivatives have been designated as hedging instruments. Amounts recognized in earnings related to excluded time value and hedge ineffectiveness were not material for the years ended December 31, 2017 and 2016.